| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 13569-80-7 | 镝箔片 | Dysprosium(III)fluoride,anhydrous,REacton | DyF3 | 219.5 | 1360℃ | 2200℃ |
| 13569-96-5 | 4-(4-溴苯基)-1h-咪唑 | 4-(4-bromophenyl)imidazole | C9H7BrN2 | 223.07 | | |
| 13569-97-6 | | 4-(1h-imidazol-4-yl)benzoic acid | C10H8N2O2 | 188.19 | | |
| 135690-29-8 | 2-amino-4,6-dibromobenzaldehyde | | C7H5Br2NO | 278.931 | | |
| 135690-47-0 | | ranatachykinin a | C60H92N16O15S | 1309.54 | | |
| 1356905-39-9 | MK-521-d5 | Lisinopril-d5 | C21H26D5N3O5 | 410.52 | | |
| 1356906-17-6 | 喹硫平ep杂质j | quetiapine ep impurity j | | | | |
| 135692-39-6 | | 8-methoxy-4,4-dimethyl-4,5-dihydro-1h-[1,2]dithiolo[3,4-c]quinoline-1-thione | | | | |
| 135692-96-5 | | gossylic lactone | | | | |
| 1356922-29-6 | Enalaprilat D5 Sodium Salt | | C18H17D5N2Na2O5 | 397.39 | | |
| 1356929-59-3 | Perindopril-d4 t-Butylamine Salt | Perindopril-d4 erbumine | C23H39D4N3O5 | 445.63 | | |
| 1356930-51-2 | 1-((2R)-2-Amino-2-cyclohexylacetyl)-N-(4’-cyanobenzyl)-2-L-azetidinecarboxamide-d11 | | C20H15D11N4O2 | 365.51 | | |
| 1356930-62-5 | Bendamustine Bis-mercapturic Acid-d6 | | C26H31D6N5O8S2 | 617.77 | | |
| 1356931-00-4 | Benzyl (2S,3S,5S)-2-Hexyl-3-benzyloxy-5-[[(S)-2-(formylamino)-4-(methyl-d3)-pentanoyl]oxy]hexadecanoate | | C43H64D3NO6 | 697.01 | | |
| 1356933-72-6 | 克林霉素-d3盐酸盐 | clindamycin-d3 hydrochloride | | | | |
| 1356933-73-7 | N-乙酰基-S-(3-羧基-2-丙基)-L-半胱氨酸-d3二钠盐 | N-Acetyl-S-(3-carboxy-2-propyl)-L-cysteine-d3 Disodium Salt | C9H10D3NNa2O5S | 296.27 | | |
| 1356933-74-8 | N-乙酰基草铵膦-d3二钠盐 | N-Acetyl Glufosinate-d3 Disodium Salt | C7H9D3NNa2O5P | 270.15 | | |
| 1356934-59-2 | N-乙酰基-S-(2-羟丙基)半胱氨酸-d3二环己基铵盐 | N-Acetyl-S-(2-hydroxypropyl)cysteine-d3 Dicyclohexylammonium Salt | C20H35D3N2O4S | 405.61 | 405.61°C | |
| 1356935-80-2 | 3-[[3,5-双(三氟甲基)苯基]氨基] -4-[[((2S)-2-吡咯烷基甲基]氨基] -3-环丁烯-1,2-二酮 | 3-[[3,5-bis(trifluoromethyl)phenyl]amino]-4-[[(2S)-2-pyrrolidinylmethyl]amino]-3-cyclobutene-1,2-dione | C17H15F6N3O2 | 407.310 | | 406.5±55.0 °C |
| 1356953-43-9 | 苄基((1R,4R)-4-((二甲基氨基)甲基)环己基)氨基甲酸酯 | benzyl ((1R,4R)-4-((dimethylamino)methyl)cyclohexyl)carbamate | | | | |
| 1356953-44-0 | 反式-4-((二甲基氨基)甲基)环己胺二乙酸酯 | trans-4-((dimethylamino)methyl)cyclohexanamine diacetate | C13H28N2O4 | 276.37 | | |
| 1356953-68-8 | | 2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | | | | |
| 1356954-01-2 | 反式-4-((二甲氨基)甲基)环己胺二盐酸盐 | trans-4-((Dimethylamino)methyl)cyclohexanamine dihydrochloride | C9H22Cl2N2 | 229.19038 | | |
| 1356962-20-3 | | azd3463 | C24H25ClN6O | 448.95 | | |
| 1356962-34-9 | | hg-14-10-04 | C29H34ClN7O | 532.08 | | |
| 1356962-86-1 | 3-(2-氯-5-(三氟甲基)嘧啶-4-基)-1H-吲哚 | 3-(2-Chloro-5-(Trifluoromethyl)Pyrimidin-4-Yl)-1H-Indole | C13H7ClF3N3 | 297.66 | | |
| 1356962-87-2 | 3-(5-溴-2-氯嘧啶-4-基)-1H-吲哚 | 3-(5-Bromo-2-chloropyrimidin-4-yl)-1H-indole | C12H7BrClN3 | 308.56 | | 533.8±40.0 °C(Predicted) |
| 1356962-89-4 | (1-(3-甲氧基-4-硝基苯基)哌啶-4-基)氨基甲酸叔丁酯 | Tert-Butyl (1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)carbamate | C17H25N3O5 | 351.4 | | |
| 1356963-19-3 | 3-(2,5-二氯嘧啶-4-基)-1-甲基-1H-吲哚 | 3-(2,5-dichloropyrimidin-4-yl)-1-methyl-1H-indole | C13H9Cl2N3 | 278.14 | | |
| 1356992-90-9 | | n-acetyl-d3-glufosinate | | | | |
| 1356998-41-8 | (4-碘-1,3-二甲基-1h-吡唑-5-基)甲醇 | (4-iodo-1,3-dimethyl-1h-pyrazol-5-yl)methanol | C6H9IN2O | 252.05 | | |
| 1356998-47-4 | 2-(3-methoxyphenyl)-1-piperazin-1-yl-ethanone;hydrochloride | | C13H18N2O2.HCl | 270.7544 | | |
| 1356999-25-1 | 1-(2,4-二氟-6-羟基苯基)乙酮 | 1-(2,4-Difluoro-6-hydroxyphenyl)ethanone | C8H6O2F2 | 172.13 | | 235.5±35.0 °C(Predicted) |
| 1357-76-2 | | 9,15-tetrol, 2-benzoate, (2-alpha,3-beta,15-beta)-hetisan-13 | | | | |
| 13570-00-8 | | 3-(1h-imidazol-2-yl)-pyridine | C8H7N3 | 145.16 | | 384.93 °C at 760 mmHg |
| 13570-08-6 | | 2-benzimidazoleacetic acid | C9H8N2O2 | 176.18 | | |
| 13570-63-3 | 醋酸去氢表雄酮 | Dehydroeplandrosterone Acetate(DHA) | | | | |
| 1357000-33-9 | 2-(金刚烷-1-基)-4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷 | 2-(Adamantan-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C16H27BO2 | 262.20 | | |
| 135701-58-5 | | [(2,4-dimethoxyphenyl)methyl](2-methylpropyl)amine | | | | |
| 135701-67-6 | | d-arg-(hyp3,d-phe7,leu8)-bradykinin | C57H89N19O13 | 1248.45 | | |
| 1357013-37-6 | | 3,4-(methylenedioxy)phenylzinc iodide 0.5 m in tetrahydrofuran | | | | |
| 135702-23-7 | | amylin fragment 8-37 human | C138H216N42O45 | 3183.48 | | |
| 135704-54-0 | btqbt(升华提纯) | btqbt (purified by sublimation) | C12H4N4S6 | 396.55 | 400°C(lit.) | |
| 135704-99-3 | | 1,2-benzisothiazol-3(2h)-one, 2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)-2-butynyl) | | | | |
| 135705-03-2 | | 1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)-2-butynyl)-5-pyrrolidinedione | | | | |
| 135707-05-0 | | copper(l) (hexafluoroacetylacetonato)trimethylphosphine | C8H10CuF6O2P | 346.67 | 65℃ | 33℃(10 t |
| 1357072-61-7 | 3-[(2-甲基-2h-吲唑-5-基)硫基]-6-(1-甲基-1h-吡唑-4-基)-1,2,4-三唑并[4,3-b]哒嗪 | c-met inhibitor 1 | C17H14N8S | 362.41 | | |
| 1357073-13-2 | 反式-1-叔丁基3-乙基-4-氨基吡咯烷-1,3-二甲酸盐酸盐 | trans-1-tert-butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate hydrochloride | | | | |
| 1357078-03-5 | (2-Oxo-2H-chromen-7-yl)boronic acid | | C9H7BO4 | 189.96 | | |
| 1357086-92-0 | 2,4-二氯-6-甲基-6h-吡咯并[3,4-d]嘧啶 | 2,4-dichloro-6-methyl-6h-pyrrolo[3,4-d]pyrimidine | C7H5Cl2N3 | 202.04 | | |
m.cnreagent.com